Original Research
Published on 03 Nov 2022
NBTXR3 improves the efficacy of immunoradiotherapy combining nonfucosylated anti-CTLA4 in an anti-PD1 resistant lung cancer model
in Cancer Immunity and Immunotherapy
- 7,321 views
- 18 citations
Original Research
Published on 03 Nov 2022
in Cancer Immunity and Immunotherapy
Mini Review
Published on 02 Apr 2026
in Pharmacology of Anti-Cancer Drugs
Original Research
Published on 08 May 2025
in Cancer Immunity and Immunotherapy
Mini Review
Published on 29 Jan 2026
in Pharmacology of Anti-Cancer Drugs
Original Research
Published on 06 Mar 2026
in Pharmacology of Anti-Cancer Drugs
Review
Published on 17 Feb 2023
in Cancer Immunity and Immunotherapy
Mini Review
Published on 08 May 2026
in Pharmacology of Anti-Cancer Drugs
Opinion
Published on 26 Mar 2026
in Pharmacology of Anti-Cancer Drugs
Original Research
Published on 05 Mar 2026
in Pharmacology of Anti-Cancer Drugs
Original Research
Published on 20 Nov 2025
in Pharmacology of Anti-Cancer Drugs
Original Research
Published on 14 Jan 2022
in Cancer Immunity and Immunotherapy
Original Research
Published on 02 Apr 2026
in Pharmacology of Anti-Cancer Drugs
Systematic Review
Published on 22 Jul 2025
in Pulmonary Medicine